LALPATHLAB (Dr. Lal Path Labs Ltd.): Order Win
Dr. Lal Path Labs Ltd. informed the exchange on 17 July that it received an appellant order from the Income Tax Department, according to an NSE filing. The company disclosed the development under general updates, with the filing timestamped at 19:40. The stock closed at ₹1,687.4 on 17 July, down 2.61% from the previous session.
Events like this—classified as "Order Win" catalysts—have historically shown a 72% win rate across 50 comparable past instances, with a net edge of 1.6%, according to Strota's base-rate data. These figures represent the historical frequency and average movement following similar disclosure events across multiple stocks, not a forecast for this specific case.
The stock trades 6.41% below its 52-week high of ₹1,803 and 32.59% above its 52-week low of ₹1,272.6. It remains above both its 50-day and 200-day simple moving averages. Relative volume at 0.66 indicates below-average trading activity. The company commands a market capitalisation of ₹28,176 crore, with a price-to-earnings ratio of 55.97 and return on equity of 21.5%.
The filing confirms receipt of the tax department order; it does not specify financial impact, timeline, or operational implications. The historical base rate offers context on how markets have processed similar corporate disclosures, but does not establish expected returns for this individual event.
The catalyst
Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Received an appellant order from Income Tax Department (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Order Win tends to continue — the move went bullish in about 72.0% of next sessions (net 1.6% after drift and cost, n=50). A base rate, not a forecast for this stock.
LALPATHLAB right now
trading -2.61% on the day; P/E 55.97; RSI 53.6. Full LALPATHLAB analysis →
Sources
- Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Received an appellant order from Income Tax Department — NSE
- Dr Lal Path Labs Ltd. Hits 52-Week High After Dubai Expansion Move and Strong FY27 Growth Guidance — India Infoline
- Upcoming Dividend, Bonus Issue, Stock Split In June 2026: Infosys, Reliance, HDFC Bank, HUL, PNB, Tata Steel — Goodreturns
- Dr. Lal PathLabs Ltd (BOM:539524) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... — GuruFocus.com
- Q4FY26 Results Calendar: Every Major Company Reporting April 30 to May 9, 2026 — Sahi
Keep digging
- LALPATHLAB — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.